{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:14:21Z","timestamp":1771272861759,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110-2314-B-075-038 -MY2, MOST 111-2314-b-075-066"],"award-info":[{"award-number":["MOST 110-2314-B-075-038 -MY2, MOST 111-2314-b-075-066"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s11060-022-04153-x","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T09:03:46Z","timestamp":1670231026000},"page":"135-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Natural history of lung squamous cell brain metastases in patients treated with radiosurgery: a thirty-year experience at a tertiary medical center"],"prefix":"10.1007","volume":"161","author":[{"given":"Yu-Chi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huai-Che","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Lu","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-I","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Hung","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Sin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Jung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yuh","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Ying","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Yuo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hung-Chi Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"issue":"5","key":"4153_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/BF00750584","volume":"412","author":"AH Graf","year":"1988","unstructured":"Graf AH, Buchberger W, Langmayr H, Schmid KW (1988) Site preference of metastatic tumours of the brain. Virchows Arch A Pathol Anat Histopathol 412(5):493\u2013498. https:\/\/doi.org\/10.1007\/BF00750584","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"3","key":"4153_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.adro.2019.11.002","volume":"5","author":"M Ramotar","year":"2019","unstructured":"Ramotar M, Barnes S, Moraes F, Dasgupta A, Laperriere N, Millar BA, Berlin A, Conrad T, van Prooijen M, Damyanovich A, Heaton R, Cho YB, Coolens C, Liu G, Shepherd FA, Bradbury P, Leighl N, Bernstein M, Zadeh G, Kongkham P, Doherty M, Shultz DB (2019) Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases. Adv Radiat Oncol 5(3):350\u2013357. https:\/\/doi.org\/10.1016\/j.adro.2019.11.002","journal-title":"Adv Radiat Oncol"},{"key":"4153_CR3","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Larraya JG, Hildebrand J (2014) Handbook of Clinical Neurology (ed): Brain metastases. Elsevier, pp 1143\u20131157. https:\/\/doi.org\/10.1016\/B978-0-7020-4088-7.00077-8","DOI":"10.1016\/B978-0-7020-4088-7.00077-8"},{"issue":"4","key":"4153_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2, Deming R, Burri SH, M\u00e9nard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL (2016) Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA 316(4):401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA"},{"issue":"11","key":"4153_CR5","doi-asserted-by":"publisher","first-page":"12318","DOI":"10.18632\/oncotarget.7131","volume":"7","author":"H Soliman","year":"2016","unstructured":"Soliman H, Das S, Larson DA, Sahgal A (2016) Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases. Oncotarget 7(11):12318\u201312330. https:\/\/doi.org\/10.18632\/oncotarget.7131","journal-title":"Oncotarget"},{"issue":"21","key":"4153_CR6","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21):2483\u20132491. https:\/\/doi.org\/10.1001\/jama.295.21.2483","journal-title":"JAMA"},{"key":"4153_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.radonc.2019.11.010","volume":"144","author":"R Singh","year":"2020","unstructured":"Singh R, Lehrer EJ, Ko S, Peterson J, Lou Y, Porter AB, Kotecha R, Brown PD, Zaorsky NG, Trifiletti DM (2020) Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches. Radiother Oncol 144:165\u2013179. https:\/\/doi.org\/10.1016\/j.radonc.2019.11.010","journal-title":"Radiother Oncol"},{"key":"4153_CR8","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","volume":"371","author":"AT Shaw","year":"2014","unstructured":"Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB, Doebele RC, Le LP, Zheng Z, Tan W, Stephenson P, Shreeve SM, Tye LM, Christensen JG, Wilner KD, Clark JW, Iafrate AJ (2014) Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer. N Engl J Med 371:1963\u20131971. https:\/\/doi.org\/10.1056\/NEJMoa1406766","journal-title":"N Engl J Med"},{"issue":"2","key":"4153_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3171\/2021.9.JNS211373","volume":"137","author":"G Chiou","year":"2022","unstructured":"Chiou G, Chiang C, Yang H, Shen C, Wu H, Chen YW, Chen CJ, Luo YH, Hu YS, Lin CJ, Chung WY, Shiau CY, Guo WY, Pan DH, Lee CC (2022) Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non\u2013small cell lung cancer patients with brain metastases. J Neurosurg 137(2):563\u2013570. https:\/\/doi.org\/10.3171\/2021.9.JNS211373","journal-title":"J Neurosurg"},{"issue":"10","key":"4153_CR10","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.jtho.2016.05.013","volume":"11","author":"T Jiang","year":"2016","unstructured":"Jiang T, Su C, Li X, Zhao C, Zhou F, Ren S, Zhou C, Zhang J (2016) EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases. J Thorac Oncol 11(10):1718\u20131728. https:\/\/doi.org\/10.1016\/j.jtho.2016.05.013","journal-title":"J Thorac Oncol"},{"issue":"36","key":"4153_CR11","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1200\/JCO.2010.28.8126","volume":"28","author":"CJ Langer","year":"2010","unstructured":"Langer CJ, Besse B, Gualberto A, Brambilla E, Soria JC (2010) The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol 28(36):5311\u20135320. https:\/\/doi.org\/10.1200\/JCO.2010.28.8126","journal-title":"J Clin Oncol"},{"issue":"4","key":"4153_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1227\/NEU.0000000000000072","volume":"73","author":"JG Kuremsky","year":"2013","unstructured":"Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG, Chan MD (2013) Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. Neurosurgery 73(4):641\u2013647 discussion 647. https:\/\/doi.org\/10.1227\/NEU.0000000000000072","journal-title":"Neurosurgery"},{"issue":"5","key":"4153_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.cllc.2017.02.001","volume":"18","author":"PM Ellis","year":"2017","unstructured":"Ellis PM, Vella ET, Ung YC (2017) Immune Checkpoint Inhibitors for Patients With Advanced Non\u2013Small-Cell Lung Cancer: A Systematic Review. Clin Lung Cancer 18(5):444\u2013459. https:\/\/doi.org\/10.1016\/j.cllc.2017.02.001","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"4153_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cllc.2020.10.014","volume":"22","author":"TL Enright","year":"2021","unstructured":"Enright TL, Witt JS, Burr AR, Yadav P, Leal T, Baschnagel AM (2021) Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non\u2013small-cell Lung Cancer Brain Metastases. Clin Lung Cancer 22(2):110\u2013119. https:\/\/doi.org\/10.1016\/j.cllc.2020.10.014","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"4153_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","volume":"373","author":"J Brahmer","year":"2015","unstructured":"Brahmer J, Reckamp KL, Baas P, Crin\u00f2 L, Eberhardt WE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, Waterhouse D, Ready N, Gainor J, Ar\u00e9n Frontera O, Havel L, Steins M, Garassino MC, Aerts JG, Domine M, Paz-Ares L, Reck M, Baudelet C, Harbison CT, Lestini B, Spigel DR (2015) Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med 373(2):123\u2013135. https:\/\/doi.org\/10.1056\/NEJMoa1504627","journal-title":"N Engl J Med"},{"key":"4153_CR16","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1056\/NEJMoa1613493","volume":"376","author":"DP Carbone","year":"2017","unstructured":"Carbone DP, Reck M, Paz-Ares L, Creelan B, Horn L, Steins M, Felip E, van den Heuvel MM, Ciuleanu TE, Badin F, Ready N, Hiltermann TJN, Nair S, Juergens R, Peters S, Minenza E, Wrangle JM, Rodriguez-Abreu D, Borghaei H, Blumenschein GR Jr, Villaruz LC, Havel L, Krejci J, Corral Jaime J, Chang H, Geese WJ, Bhagavatheeswaran P, Chen AC, Socinski MA, CheckMate 026 Investigators (2017) First-line nivolumab in stage IV or recurrent non-small-cell lung cancer. N Engl J Med 376:2415\u20132426. https:\/\/doi.org\/10.1056\/NEJMoa1613493","journal-title":"N Engl J Med"},{"issue":"30","key":"4153_CR17","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1200\/JCO.2016.71.7629","volume":"35","author":"R Govindan","year":"2017","unstructured":"Govindan R, Szczesna A, Ahn MJ, Schneider CP, Gonzalez Mella PF, Barlesi F, Han B, Ganea DE, Von Pawel J, Vladimirov V, Fadeeva N, Lee KH, Kurata T, Zhang L, Tamura T, Postmus PE, Jassem J, O\u2019Byrne K, Kopit J, Li M, Tschaika M, Reck M (2017) Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer. J Clin Oncol 35(30):3449\u20133457. https:\/\/doi.org\/10.1200\/JCO.2016.71.7629","journal-title":"J Clin Oncol"},{"key":"4153_CR18","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, Baas P, Kim DW, Felip E, P\u00e9rez-Gracia JL, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, Majem M, Fidler MJ, de Castro G Jr, Garrido M, Lubiniecki GM, Shentu Y, Im E, Dolled-Filhart M, Garon EB (2016) Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. The Lancet 387:1540\u20131550. https:\/\/doi.org\/10.1016\/S0140-6736(15)01281-7","journal-title":"The Lancet"},{"key":"4153_CR19","unstructured":"Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Guideline Non-Small Cell Lung Cancer V.3 (2022) \u00a9 National Comprehensive Cancer Network, Inc. 2022. All rights reserved. Accessed [Aug 10, 2022]. To view the most recent and complete version of the guideline, go online to NCCN.org"},{"key":"4153_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11060-018-2980-8","volume":"140","author":"CC Lee","year":"2018","unstructured":"Lee CC, Chou CL, Chen CJ, Yang HC, Wu HM, Shiau CY, Pan DH, Chung WY (2018) Stereotactic radiosurgery for hypervascular intracranial tumors. J Neurooncol 140:547\u2013558. https:\/\/doi.org\/10.1007\/s11060-018-2980-8","journal-title":"J Neurooncol"},{"issue":"Suppl","key":"4153_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3171\/2012.8.GKS121066","volume":"117","author":"CC Lee","year":"2012","unstructured":"Lee CC, Pan DH, Chung WY, Liu KD, Yang HC, Wu HM, Guo WY, Shih YH (2012) Brainstem cavernous malformations: the role of Gamma Knife surgery. J Neurosurg 117(Suppl):164\u2013169. https:\/\/doi.org\/10.3171\/2012.8.GKS121066","journal-title":"J Neurosurg"},{"key":"4153_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11060-014-1439-9","volume":"118","author":"CC Lee","year":"2014","unstructured":"Lee CC, Wintermark M, Xu Z, Yen CP, Schlesinger D, Sheehan JP (2014) Application of diffusion-weighted magnetic resonance imaging to predict the intracranial metastatic tu- mor response to gamma knife radiosurgery. J Neurooncol 118:351\u2013361. https:\/\/doi.org\/10.1007\/s11060-014-1439-9","journal-title":"J Neurooncol"},{"key":"4153_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3171\/2013.9.JNS131163","volume":"120","author":"CC Lee","year":"2014","unstructured":"Lee CC, Yen CP, Xu Z, Schlesinger D, Sheehan J (2014) Large intracranial metastatic tumors treated by Gamma Knife surgery: outcomes and prognostic factors. J Neurosurg 120:52\u201359. https:\/\/doi.org\/10.3171\/2013.9.JNS131163","journal-title":"J Neurosurg"},{"key":"4153_CR24","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"DW Andrews","year":"2004","unstructured":"Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665\u20131672. https:\/\/doi.org\/10.1016\/S0140-6736(04)16250-8","journal-title":"Lancet"},{"issue":"2","key":"4153_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0360-3016(99)00507-6","volume":"47","author":"E Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90 \u2013 05. Int J Radiat Oncol Biol Phys 47(2):291\u2013298. https:\/\/doi.org\/10.1016\/s0360-3016(99)00507-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4153_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijrobp.2017.01.201","volume":"98","author":"M Farris","year":"2017","unstructured":"Farris M, McTyre ER, Cramer CK, Hughes R, Randolph DM 2nd, Ayala-Peacock DN, Bourland JD, Ruiz J, Watabe K, Laxton AW, Tatter SB, Zhou X, Chan MD (2017) Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone. Int J Radiat Oncol Biol Phys 98(1):131\u2013141. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.01.201","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4153_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3171\/2018.10.JNS181371","volume":"132","author":"C Singh","year":"2019","unstructured":"Singh C, Qian JM, Yu JB, Chiang VL (2019) Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non\u2013small cell lung cancer with brain metastases. J Neurosurg JNS 132(2):512\u2013517. https:\/\/doi.org\/10.3171\/2018.10.JNS181371","journal-title":"J Neurosurg JNS"},{"issue":"16","key":"4153_CR28","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1158\/0008-5472.CAN-12-3775","volume":"73","author":"JL Breindel","year":"2013","unstructured":"Breindel JL, Haskins JW, Cowell EP, Zhao M, Nguyen DX, Stern DF (2013) EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis. Cancer Res 73(16):5053\u20135065. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3775","journal-title":"Cancer Res"},{"issue":"3","key":"4153_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s1556-0864(15)31569-0","volume":"1","author":"AA Shi","year":"2006","unstructured":"Shi AA, Digumarthy SR, Temel JS, Halpern EF, Kuester LB, Aquino SL (2006) Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer? J Thorac Oncol 1(3):205\u2013210. https:\/\/doi.org\/10.1016\/s1556-0864(15)31569-0","journal-title":"J Thorac Oncol"},{"key":"4153_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1148\/RADIOL.2423051707","volume":"242 3","author":"A Mujoomdar","year":"2007","unstructured":"Mujoomdar A, Austin J, Malhotra R, Powell C, Pearson G, Shiau M, Raftopoulos H (2007) Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology 242 3:882\u2013888. https:\/\/doi.org\/10.1148\/RADIOL.2423051707","journal-title":"Radiology"},{"issue":"2","key":"4153_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.lungcan.2012.03.028","volume":"77","author":"S Guo","year":"2012","unstructured":"Guo S, Reddy CA, Chao ST, Suh JH, Barnett GH, Vogelbaum MA, Videtic GM (2012) Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases. Lung Cancer 77(2):389\u2013393. https:\/\/doi.org\/10.1016\/j.lungcan.2012.03.028","journal-title":"Lung Cancer"},{"issue":"2","key":"4153_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0169-5002(98)00039-7","volume":"21","author":"MLG Janssen-Heijnen","year":"1998","unstructured":"Janssen-Heijnen MLG, Schipper RM, Razenberg PPA, Crommelin MA, Coebergh JWW (1998) Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: A population-based study. Lung Cancer 21(2):105\u2013113. https:\/\/doi.org\/10.1016\/s0169-5002(98)00039-7","journal-title":"Lung Cancer"},{"key":"4153_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00280-012-1997-5","volume":"71","author":"CL Chiang","year":"2013","unstructured":"Chiang CL, Tsai CM, Chou TY, Chen YM, Lai SL, Shih JF, Chiu CH, Lee YC (2013) Erlotinib in patients with advanced lung squamous cell carcinoma. Cancer Chemother Pharmacol 71:203\u2013208. https:\/\/doi.org\/10.1007\/s00280-012-1997-5","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"4153_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.lungcan.2012.02.012","volume":"77","author":"JS Tseng","year":"2012","unstructured":"Tseng JS, Yang TY, Chen KC, Hsu KH, Chen HY, Chang GC (2012) Retrospective study of erlotinib in patients with advanced squamous lung cancer. Lung Cancer 77(1):128\u2013133. https:\/\/doi.org\/10.1016\/j.lungcan.2012.02.012","journal-title":"Lung Cancer"},{"issue":"12","key":"4153_CR35","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/jjco\/hyr159","volume":"41","author":"A Hata","year":"2011","unstructured":"Hata A, Katakami N, Kunimasa K, Yoshioka H, Fujita S, Kaji R, Tachikawa R, Tomii K, Imai Y, Iwasaku M, Ishida T (2011) Erlotinib for Pretreated Squamous Cell Carcinoma of the Lung in Japanese Patients. Jpn J Clin Oncol 41(12):1366\u20131372. https:\/\/doi.org\/10.1093\/jjco\/hyr159","journal-title":"Jpn J Clin Oncol"},{"key":"4153_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clineuro.2017.12.021","volume":"165","author":"CM Lanier","year":"2018","unstructured":"Lanier CM, McTyre E, LeCompte M, Cramer CK, Hughes R, Watabe K, Lo HW, O\u2019Neill S, Munley MT, Laxton AW, Tatter SB, Ruiz J, Chan MD (2018) The number of prior lines of systemic therapy as a prognostic factor for patients with brain metastases treated with stereotactic radiosurgery: Results of a large single institution retrospective analysis. Clin Neurol Neurosurg 165:24\u201328. https:\/\/doi.org\/10.1016\/j.clineuro.2017.12.021","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"4153_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3171\/2019.4.JNS19446","volume":"133","author":"CC Lee","year":"2019","unstructured":"Lee CC, Hsu SPC, Lin CJ, Wu HM, Chen YW, Luo YH, Chiang CL, Hu YS, Chung WY, Shiau CY, Guo WY, Hung-Chi Pan D, Yang HC (2019) Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non\u2013small cell lung cancer and brain metastases. J Neurosurg JNS 133(2):313\u2013320. https:\/\/doi.org\/10.3171\/2019.4.JNS19446","journal-title":"J Neurosurg JNS"},{"issue":"28","key":"4153_CR38","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1200\/JCO.19.00934","volume":"37","author":"EB Garon","year":"2019","unstructured":"Garon EB, Hellmann MD, Rizvi NA, Carcereny E, Leighl NB, Ahn MJ, Eder JP, Balmanoukian AS, Aggarwal C, Horn L, Patnaik A, Gubens M, Ramalingam SS, Felip E, Goldman JW, Scalzo C, Jensen E, Kush DA, Hui R (2019) Five-Year Overall Survival for Patients With Advanced Non\u2013Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study. J Clin Oncol 37(28):2518\u20132527. https:\/\/doi.org\/10.1200\/JCO.19.00934","journal-title":"J Clin Oncol"},{"issue":"10066","key":"4153_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","volume":"389","author":"A Rittmeyer","year":"2017","unstructured":"Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols MC, Cortinovis DL, Leach J, Polikoff J, Barrios C, Kabbinavar F, Frontera OA, De Marinis F, Turna H, Lee JS, Ballinger M, Kowanetz M, He P, Chen DS, Sandler A, Gandara DR, OAK Study Group (2017) Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet 389(10066):255\u2013265. https:\/\/doi.org\/10.1016\/S0140-6736(16)32517-X","journal-title":"Lancet"},{"issue":"21","key":"4153_CR40","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","volume":"379","author":"L Paz-Ares","year":"2018","unstructured":"Paz-Ares L, Luft A, Vicente D, Tafreshi A, G\u00fcm\u00fc\u015f M, Mazi\u00e8res J, Hermes B, \u00c7ay \u015eenler F, Cs\u0151szi T, F\u00fcl\u00f6p A, Rodr\u00edguez-Cid J, Wilson J, Sugawara S, Kato T, Lee KH, Cheng Y, Novello S, Halmos B, Li X, Lubiniecki GM, Piperdi B, Kowalski DM, KEYNOTE-407 Investigators (2018) Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer. N Engl J Med 379(21):2040\u20132051. https:\/\/doi.org\/10.1056\/NEJMoa1810865","journal-title":"N Engl J Med"},{"issue":"9","key":"4153_CR41","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/jamaoncol.2021.2209","volume":"7","author":"SN Gettinger","year":"2021","unstructured":"Gettinger SN, Redman MW, Bazhenova L, Hirsch FR, Mack PC, Schwartz LH, Bradley JD, Stinchcombe TE, Leighl NB, Ramalingam SS, Tavernier SS, Yu H, Unger JM, Minichiello K, Highleyman L, Papadimitrakopoulou VA, Kelly K, Gandara DR, Herbst RS (2021) Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial. JAMA Oncol 7(9):1368\u20131377. https:\/\/doi.org\/10.1001\/jamaoncol.2021.2209","journal-title":"JAMA Oncol"},{"issue":"1","key":"4153_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13073-022-01079-x","volume":"14","author":"M Yang","year":"2022","unstructured":"Yang M, Lin C, Wang Y, Chen K, Zhang H, Li W (2022) Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance. Genome Med 14(1):72. https:\/\/doi.org\/10.1186\/s13073-022-01079-x","journal-title":"Genome Med"},{"issue":"20","key":"4153_CR43","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.7150\/jca.27441","volume":"9","author":"F Pan","year":"2018","unstructured":"Pan F, Cui S, Wang W, Gu A, Jiang L (2018) Survival analysis for lung adenosquamous carcinoma patients with brain metastasis. J Cancer 9(20):3707\u20133712. https:\/\/doi.org\/10.7150\/jca.27441","journal-title":"J Cancer"},{"issue":"2","key":"4153_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ejcts.2011.05.050","volume":"41","author":"H Maeda","year":"2012","unstructured":"Maeda H, Matsumura A, Kawabata T, Suito T, Kawashima O, Watanabe T, Okabayashi K, Kubota I, for the Japan National Hospital Organization Study Group for Lung Cancer (2012) Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases. Eur J Cardiothorac Surg 41(2):357\u2013361. https:\/\/doi.org\/10.1016\/j.ejcts.2011.05.050","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04153-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-022-04153-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04153-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T09:06:11Z","timestamp":1675069571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-022-04153-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["4153"],"URL":"https:\/\/doi.org\/10.1007\/s11060-022-04153-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"11 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements and Declarations"}},{"value":"The authors have no relevant disclosures to make.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure Statement"}},{"value":"None of the authors have any conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study is restrospective in nature and the patients\u2019 data are analysed anonymously, therefore the Institutional Review Board states that no ethics approval is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent to participate was provided by all patients.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Written informed consent to publish was provided by all patients.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}